Current Shortage Status
Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets
Medium NHSBSA SSPDoncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of certain parallel imported batches of Hiprex 1 g tablets (POM).
What to Do If You're Affected
- Contact your pharmacy as soon as possible — don't wait until you run out
- Ask your pharmacist if a Serious Shortage Protocol (SSP) is active
- Speak to your GP about prescribing an alternative
- Try other local pharmacies who may have different stock
- Sign up for MediWatch alerts to track this shortage
Frequently Asked Questions
Is Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex in shortage in the UK in 2026?
Yes — as of 22 April 2026, there is 1 active shortage notification for Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex in the UK, issued by DHSC or NHSBSA. Sign up for MediWatch alerts to be notified of any changes.
What is Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex used for?
Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex is commonly prescribed in the UK for various medical conditions. It is dispensed through NHS pharmacies across the country.
What should I do if I can't get Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex from my pharmacy?
First, ask your pharmacist if a Serious Shortage Protocol (SSP) is active — this may allow them to dispense an alternative without a new prescription. If not, contact your GP who can prescribe a suitable alternative. Try other local pharmacies as stock levels vary by location.
Page last updated: 22 April 2026. Data checked daily.